情報リーフレット
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT:
CALIERMUTIN 20mg/g PREMIX (ES)
CALIERMUTIN 20 mg/g prè-mistura para alimento medicamentoso para suinos e
coelhos (PT)
2. QUALITATIVE AND QUANTITATIVE COMPOSITION:
ACTIVE SUBSTANCE:
Tiamulin hydrogen fumarate………………..20 mg
(Equivalent to 16.2 mg of Tiamulin)
EXCIPIENTS:
Excipient q.s. ...................................................................................1 g
_ _
For a full list of excipients, see section 6.1
_ _
3. PHARMACEUTICAL FORM:
Premix for medicated feeding stuff as granulated powder
4. CLINICAL PARTICULARS:
4.1 TARGET SPECIES:
Pigs and rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES:
PIGS:
Treatment and prevention of porcine dysentery caused by _B. hyodysenteriae. _
Treatment and prevention, proliferative enteritis (ileitis), caused by _Lawsonia _
_intracellularis_
Treatment of enzootic pneumonia caused by _M. hyopneumoniae. _
RABBITS:
Treatment and prevention of epizootic entercolitis.
The presence of disease in the herd should be established before treatment.
4.3 CONTRAINDICATIONS:
Do not administer with ionophore polyether antibiotics as salinomycin, monensin or
narasin.
Do not use in case of hypersensitivity to the active substance, or to any of the
excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In pigs and rabbits do not administer with ionophore polyether antibiotics.
The uptake of medicated feed by animals can be altered as a consequence of illness.
In case of insufficient feed intake, animals should be treated parenterally.
4.5. SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMAL
完全なドキュメントを読む
製品の特徴
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT:
CALIERMUTIN 20mg/g PREMIX (ES)
CALIERMUTIN 20 mg/g prè-mistura para alimento medicamentoso para suinos e
coelhos (PT)
2. QUALITATIVE AND QUANTITATIVE COMPOSITION:
ACTIVE SUBSTANCE:
Tiamulin hydrogen fumarate………………..20 mg
(Equivalent to 16.2 mg of Tiamulin)
EXCIPIENTS:
Excipient q.s. ...................................................................................1 g
_ _
For a full list of excipients, see section 6.1
_ _
3. PHARMACEUTICAL FORM:
Premix for medicated feeding stuff as granulated powder
4. CLINICAL PARTICULARS:
4.1 TARGET SPECIES:
Pigs and rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES:
PIGS:
Treatment and prevention of porcine dysentery caused by _B. hyodysenteriae. _
Treatment and prevention, proliferative enteritis (ileitis), caused by _Lawsonia _
_intracellularis_
Treatment of enzootic pneumonia caused by _M. hyopneumoniae. _
RABBITS:
Treatment and prevention of epizootic entercolitis.
The presence of disease in the herd should be established before treatment.
4.3 CONTRAINDICATIONS:
Do not administer with ionophore polyether antibiotics as salinomycin, monensin or
narasin.
Do not use in case of hypersensitivity to the active substance, or to any of the
excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In pigs and rabbits do not administer with ionophore polyether antibiotics.
The uptake of medicated feed by animals can be altered as a consequence of illness.
In case of insufficient feed intake, animals should be treated parenterally.
4.5. SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMAL
完全なドキュメントを読む